
Scotaz P 4000mg/500mg Injection
Marketer
Nova Scotia
Salt Composition
Piperacillin (4000mg) + Tazobactum (500mg)
Overview Scotaz P 4000mg/500mg Injection
Combiflox 4000mg/500mg injection, a dual-antibiotic formulation, combats diverse bacterial infections by eliminating microorganisms. Administered solely by medical professionals, dosage and frequency are determined by the physician based on individual health status. Strict adherence to prescribed usage is crucial. Potential side effects, including nausea, vomiting, diarrhea, and skin rashes, or injection site reactions such as pain, swelling, or redness, may occur. Persistent or worsening side effects warrant immediate medical consultation. Prior to use, disclose any antibiotic allergies, kidney or liver conditions; adjustments to dosage or alternative medications may be necessary. Generally safe for pregnant and breastfeeding individuals under medical guidance.
Uses of Scotaz P 4000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Scotaz P 4000mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Scotaz P 4000mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
- Allergic reaction
How to use Scotaz P 4000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Scotaz P 4000mg/500mg Injection works:
The injectable formulation Scotaz P (4000mg/500mg) unites piperacillin, a potent antibiotic, with tazobactam, a beta-lactamase inhibitor. Piperacillin's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactam's role is to counteract bacterial resistance mechanisms, thereby boosting piperacillin's effectiveness.
SAFETY ADVICE
AlcoholSAFE
No adverse reactions are associated with the concomitant use of alcohol and Scotaz P 4000mg/500mg Injection.
PregnancySAFE IF PRESCRIBED
The injectable medication Scotaz P (4000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; clinical data from human subjects, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Scotaz P, 4000mg/500mg, presents no known breastfeeding contraindications. Research in human subjects indicates negligible transfer of the drug into breast milk, posing no identified risk to infants.
DrivingCONSULT YOUR DOCTOR
The impact of Scotaz P 4000mg/500mg Injection on driving ability is undetermined. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.
KidneyCAUTION
The use of Scotaz P 4000mg/500mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Scotaz P 4000mg/500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Scotaz P 4000mg/500mg Injection in patients with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification for this medication may be unnecessary in such individuals. Physician consultation is advised.
What if you forget to take Scotaz P 4000mg/500mg Injection :
Should you inadvertently omit a scheduled dose of Scotaz P 4000mg/500mg Injection, seek guidance from your physician.
Facts to Know About Scotaz P 4000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
